Summary
Becton Dickinson & Co (BDX) has filed an 8-K report detailing the completion of the separation and distribution of its diabetes care business, now operating as an independent public company named embecta Corp. (embecta), trading under the symbol EMBC on the Nasdaq Global Select Market. This event, effective April 1, 2022, involved distributing 100% of embecta's shares to BDX stockholders. As a result of this separation, two directors, Claire Pomeroy and David F. Melcher, resigned from the BDX board to join embecta's board, and the size of the BDX board has been reduced to eleven directors. In connection with the separation, BDX and embecta entered into a Separation and Distribution Agreement to govern their post-separation relationship. Furthermore, BDX received $200 million in senior secured notes from embecta and, through a debt-for-debt exchange with Morgan Stanley, effectively refinanced $199 million of its own floating rate notes. BDX's prior guarantee of embecta's credit facility and senior notes was also automatically released upon the completion of the distribution. Investors should note that this filing primarily confirms the operational separation and associated financial transactions, with further details on the separation agreement available in accompanying exhibits and embecta's filings.
Key Highlights
- 1Becton Dickinson (BDX) has successfully completed the separation and distribution of its diabetes care business, now named embecta Corp. (EMBC).
- 2embecta is now an independent public company trading on the Nasdaq Global Select Market under the ticker symbol EMBC.
- 3BDX shareholders of record on March 22, 2022, received one share of embecta for every five shares of BDX held.
- 4Two BDX directors, Claire Pomeroy and David F. Melcher, resigned from the BDX board to join embecta's board.
- 5The size of the BDX Board of Directors has been reduced to eleven members following the separation.
- 6BDX received $200 million in senior secured notes from embecta as part of the separation consideration.
- 7BDX exchanged these embecta notes for $199 million of its own floating rate notes through a tender offer and exchange with Morgan Stanley, effectively managing its debt.